4DMedical secures $30.2 million with options underwrite
Filed with ASX · · 6 pages · English
Summary by 6ix AI
4DMedical Ltd. has secured significant funding through an underwriting agreement for its listed options, ensuring the exercise of all options issued. This funding will enhance the company's cash balance, positioning it for future growth and commercial opportunities. The company is experiencing heightened interest in its CT:VQ technology, indicating a transformative year ahead.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from 4DMedical
- University of Miami adopts CTVQ
- 4DMedical secures US$10m CTVQ orders in Philips deal
- CTVQ commercial rollout commences at Stanford
- 4DMedical secures $22.6 million via exercise of options
- Supplementary announcement - 4DX agreements
Later from 4DMedical
- 4DMedical secures regulatory approval for CTVQ in Canada
- Cleveland Clinic adopts CTVQ
- UC San Diego Health adopts CTVQ
- Trading Halt
- 4DMedical completes $150 million institutional placement
Follow 4DMedical into a list and get an email when it puts out news.
Follow 4DMedical